Nationally Commissioned Service • Specialist Advice • Remote MDT • Patient Support
Chronic and allergic aspergillosis remain significantly under-recognised across the UK — despite their substantial burden on respiratory, infectious disease, and immunology services.
As the NHS England–commissioned National Aspergillosis Centre (NAC), based at Wythenshawe Hospital (Manchester University NHS Foundation Trust), we provide national expertise, remote support, and shared-care pathways for clinicians managing these complex conditions.
📊 Why This Matters
Chronic pulmonary aspergillosis (CPA) affects an estimated 3–4 per 100,000 people in the UK, with far higher rates in those with:
-
Previous tuberculosis
-
COPD
-
Non-tuberculous mycobacterial (NTM) lung disease
-
Sarcoidosis
-
Bronchiectasis
Allergic bronchopulmonary aspergillosis (ABPA) may affect:
-
2.5% of adult asthmatics
-
Up to 15% of people with cystic fibrosis
Yet both conditions are frequently undiagnosed or misdiagnosed, leading to delayed treatment and avoidable morbidity.
🏥 How NAC Supports Clinicians Across the UK
As the nationally commissioned centre for chronic aspergillosis, we offer:
🩺 Specialist clinical care
Face-to-face and remote clinics with structured long-term follow-up in partnership with local teams.
👥 National Aspergillosis MDT via Teams Remote Communication
A dedicated MDT where clinicians can refer and discuss complex diagnostic or therapeutic cases.
📧 Consultant-led advice & guidance
Available via phone & email, including:
-
Diagnostic support
-
Interpretation of IgE/IgG and fungal microbiology
-
Antifungal prescribing advice
-
Case planning for ABPA, CPA, SAFS and Aspergillus bronchitis
🔬 Access to advanced diagnostics
Including Aspergillus-specific IgE/IgG, culture, imaging, and molecular testing (e.g. antifungal resistance).
💬 Patient support & education (NAC CARES)
Moderated online groups, weekly patient meetings, webinars, and comprehensive educational resources — helping patients understand their condition and remain safely supported close to home.
🤝 We Welcome Collaboration
We’d be pleased to connect with respiratory, ID, immunology, and internal medicine teams to discuss:
-
Shared-care pathways
-
Diagnostic support
-
Service guidance
-
Virtual or in-person educational sessions
-
Case-specific MDT referrals
📄 Further information
Referral pathways, service scope and patient resources:
👉 https://mft.nhs.uk/wythenshawe/services/infectious-diseases/national-aspergillosis-centre/
Dr Chris Kosmidis
Clinical Lead, NHS National Aspergillosis Centre
Manchester University NHS Foundation Trust
Share this post
Latest News posts
Why do some people cough up long, tube-shaped pieces of mucus?
December 5, 2025
**Understanding Your Immune System:
December 5, 2025
**Where Do All These Immune Cells Live, and Where Are They Made?
December 4, 2025
**Eosinophils and Type-2 Inflammation:
December 4, 2025
**What Happens in Autoimmune Disease?
December 4, 2025
**How the Immune System Knows What Is “Self”:
December 4, 2025
**Pain Perception and Aspergillosis:
December 4, 2025
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- CPA
- Carers & Family
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Research
- NAC Announcements
- Professional Guidance
- Recordings
- Research
- Research Summaries
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel & Insurance
- Treatment
- Vaccines
- Weekly Updates
